Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plenadren vs Conventional Hydrocortisone in Secondary Adrenal Insufficiency
NCT02282150Phase 4Unknown
- Start
- Oct 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of hydrocortisone in Secondary adrenal insufficiency (SAI). Primary endpoint: Ecological Momentary Assessment fatigue profiles at 25 days. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
Secondary adrenal insufficiency (SAI)
Beyond the preview
Go deeper on NCT02282150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282150.